Floatz logo

SIMVASTATIN

Germ Cell Tumors

Emory UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

25 Active assets in the Germ Cell Tumors cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 3BB
ETOPOSIDE
Nabil Adra
Phase 3BB
Pembrolizumab
Hoffmann-La Roche
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Hoffmann-La Roche
Phase 3BB
Carboplatin
Hoffmann-La Roche
Phase 3BB

View all 48 →

Same molecule, other indications

SIMVASTATIN is also rated in:

HypercholesterolemiaDormant
BBB
Indicative ·
76 / 100
View asset →
psychotic disorderDormant
BBB
Indicative ·
75 / 100
View asset →
inherited lipid metabolism disorderDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →